Florence, SC, United States of America

Christopher G King

This inventor holds 10 USPTO granted patents, plus 2 CIPO patents. Top assignees: General Electric Company, Ge Medical Systems Global Technology Company, LLC. Active years: 1994-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher G King. Retrieved from https://idiyas.com/inventor/christopher-g-king

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 52(Granted Patents)


Location History:

  • Florence, SC (US) (1994 - 1997)
  • Monroe, CT (US) (2003)

Company Filing History:


Years Active: 1994-2003

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Inventor Christopher G King: Revolutionizing Industries

Introduction: Christopher G King, a visionary inventor hailing from Florence, SC (US), has been at the forefront of groundbreaking innovations in various industries.

Latest Patents: Christopher G King's latest patents include cutting-edge technologies in renewable energy, healthcare devices, and advanced manufacturing processes.

Career Highlights: With a career spanning over two decades, Christopher G King has a proven track record of transforming ideas into tangible inventions that have significantly impacted the market.

Collaborations: Throughout his career, Christopher G King has collaborated with leading research institutions, universities, and top companies to bring his inventions to life and ensure their commercial success.

Conclusion: Christopher G King's relentless passion for innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…